3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Medulloblastoma
2
Wilms Tumor
1
Sarcoma, Ewing
1
Rhabdomyosarcoma
1
Rhabdoid Tumor
1
Retinoblastoma
1
Pinealoma
1
Neuroectodermal Tumors, Primitive
1
Neuroblastoma
1
Meningeal Neoplasms
1
Hepatoblastoma
1
Ependymoma
1
Interventions
X-Rays
6
Phantoms, Imaging
6
Magnetic Resonance Spectroscopy
6
Specimen Handling
5
Nuclear Medicine Department, Hospital
5
Biopsy
4
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
palbociclib
2
larotrectinib
2
ivosidenib
2
erdafitinib
2
ensartinib
2
Temozolomide
2
LY3023414
2
Etoposide
2
thymoglobulin
1
temsirolimus
1
talazoparib
1
olaparib
1
irinotecan sucrosofate
1
fludarabine phosphate
1
amino-acid, glucose, and electrolyte solution
1
Vincristine
1
Vemurafenib
1
Thiotepa
1
Tacrolimus
1
Surgical Procedures, Operative
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neuroectodermal Tumors, Primitive, Peripheral
×
omburtamab I-131
×
1 year
×
Clear all
No trials found.